Filing metadata

Accession number
0001104659-24-004190
Form type
Form 3
Filer
NRX Pharmaceuticals, Inc.
CIK
CIK 1719406
Filed
Jan 16, 2024
Reporting period
Dec 28, 2023
Description
Initial ownership

Explore SEC Filings Hub